FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282933029> ?p ?o ?g. }

• W4282933029 endingPage "472" @default.
• W4282933029 startingPage "467" @default.
• W4282933029 abstract "Abstract Objectives Autoantibody seroconversion has been extensively studied in the context of COVID-19 infection but data regarding post-vaccination autoantibody production is lacking. Here we aimed to determine the incidence of common autoantibody formation following mRNA COVID-19 vaccines in patients with inflammatory arthritis (IA) and in healthy controls. Methods Autoantibody seroconversion was measured by serum ELISA in a longitudinal cohort of IA participants and healthy controls before and after COVID-19 mRNA-based immunization. Results Overall, there was a significantly lower incidence of ANA seroconversion in participants who did not contract COVID-19 prior to vaccination compared with those who been previously infected (7.4% vs 24.1%, P = 0.014). Incidence of de novo anti-CCP seroconversion in all participants was low at 4.9%. Autoantibody levels were typically of low titre, transient, and not associated with increase in IA flares. Conclusions In both health and inflammatory arthritis, the risk of autoantibody seroconversion is lower following mRNA-based immunization than following natural SARS-CoV-2 infection. Importantly, seroconversion does not correlate with self-reported IA disease flare risk, further supporting the encouragement of mRNA-based COVID-19 immunization in the IA population." @default.
• W4282933029 created "2022-06-16" @default.
• W4282933029 creator A5002869472 @default.
• W4282933029 creator A5003658474 @default.
• W4282933029 creator A5023559693 @default.
• W4282933029 creator A5030049963 @default.
• W4282933029 creator A5032622491 @default.
• W4282933029 creator A5032924701 @default.
• W4282933029 creator A5032940336 @default.
• W4282933029 creator A5042493636 @default.
• W4282933029 creator A5043550255 @default.
• W4282933029 creator A5044238862 @default.
• W4282933029 creator A5044993439 @default.
• W4282933029 creator A5048681993 @default.
• W4282933029 creator A5056886091 @default.
• W4282933029 creator A5059734573 @default.
• W4282933029 creator A5064116200 @default.
• W4282933029 creator A5067276401 @default.
• W4282933029 creator A5089511600 @default.
• W4282933029 creator A5090724029 @default.
• W4282933029 creator A5090946367 @default.
• W4282933029 creator A5091871404 @default.
• W4282933029 date "2022-05-28" @default.
• W4282933029 modified "2023-10-12" @default.
• W4282933029 title "Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis" @default.
• W4282933029 cites W2801343089 @default.
• W4282933029 cites W3018029174 @default.
• W4282933029 cites W3035882439 @default.
• W4282933029 cites W3088728509 @default.
• W4282933029 cites W3093252727 @default.
• W4282933029 cites W3094906854 @default.
• W4282933029 cites W3126044452 @default.
• W4282933029 cites W3157578989 @default.
• W4282933029 cites W3164513520 @default.
• W4282933029 cites W3192715231 @default.
• W4282933029 cites W3197281224 @default.
• W4282933029 cites W3198936050 @default.
• W4282933029 cites W4214690010 @default.
• W4282933029 doi "https://doi.org/10.1093/rheumatology/keac322" @default.
• W4282933029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35640110" @default.
• W4282933029 hasPublicationYear "2022" @default.
• W4282933029 type Work @default.
• W4282933029 citedByCount "7" @default.
• W4282933029 countsByYear W42829330292022 @default.
• W4282933029 countsByYear W42829330292023 @default.
• W4282933029 crossrefType "journal-article" @default.
• W4282933029 hasAuthorship W4282933029A5002869472 @default.
• W4282933029 hasAuthorship W4282933029A5003658474 @default.
• W4282933029 hasAuthorship W4282933029A5023559693 @default.
• W4282933029 hasAuthorship W4282933029A5030049963 @default.
• W4282933029 hasAuthorship W4282933029A5032622491 @default.
• W4282933029 hasAuthorship W4282933029A5032924701 @default.
• W4282933029 hasAuthorship W4282933029A5032940336 @default.
• W4282933029 hasAuthorship W4282933029A5042493636 @default.
• W4282933029 hasAuthorship W4282933029A5043550255 @default.
• W4282933029 hasAuthorship W4282933029A5044238862 @default.
• W4282933029 hasAuthorship W4282933029A5044993439 @default.
• W4282933029 hasAuthorship W4282933029A5048681993 @default.
• W4282933029 hasAuthorship W4282933029A5056886091 @default.
• W4282933029 hasAuthorship W4282933029A5059734573 @default.
• W4282933029 hasAuthorship W4282933029A5064116200 @default.
• W4282933029 hasAuthorship W4282933029A5067276401 @default.
• W4282933029 hasAuthorship W4282933029A5089511600 @default.
• W4282933029 hasAuthorship W4282933029A5090724029 @default.
• W4282933029 hasAuthorship W4282933029A5090946367 @default.
• W4282933029 hasAuthorship W4282933029A5091871404 @default.
• W4282933029 hasBestOaLocation W42829330291 @default.
• W4282933029 hasConcept C120665830 @default.
• W4282933029 hasConcept C121332964 @default.
• W4282933029 hasConcept C126322002 @default.
• W4282933029 hasConcept C159654299 @default.
• W4282933029 hasConcept C163764329 @default.
• W4282933029 hasConcept C203014093 @default.
• W4282933029 hasConcept C22070199 @default.
• W4282933029 hasConcept C2777077863 @default.
• W4282933029 hasConcept C2777451964 @default.
• W4282933029 hasConcept C2780801004 @default.
• W4282933029 hasConcept C61511704 @default.
• W4282933029 hasConcept C71924100 @default.
• W4282933029 hasConcept C72563966 @default.
• W4282933029 hasConceptScore W4282933029C120665830 @default.
• W4282933029 hasConceptScore W4282933029C121332964 @default.
• W4282933029 hasConceptScore W4282933029C126322002 @default.
• W4282933029 hasConceptScore W4282933029C159654299 @default.
• W4282933029 hasConceptScore W4282933029C163764329 @default.
• W4282933029 hasConceptScore W4282933029C203014093 @default.
• W4282933029 hasConceptScore W4282933029C22070199 @default.
• W4282933029 hasConceptScore W4282933029C2777077863 @default.
• W4282933029 hasConceptScore W4282933029C2777451964 @default.
• W4282933029 hasConceptScore W4282933029C2780801004 @default.
• W4282933029 hasConceptScore W4282933029C61511704 @default.
• W4282933029 hasConceptScore W4282933029C71924100 @default.
• W4282933029 hasConceptScore W4282933029C72563966 @default.
• W4282933029 hasFunder F4320308971 @default.
• W4282933029 hasFunder F4320337362 @default.
• W4282933029 hasIssue "1" @default.
• W4282933029 hasLocation W42829330291 @default.
• W4282933029 hasLocation W42829330292 @default.

• next